BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34170209)

  • 1. Novel tigecycline resistance mechanisms in
    Hua X; He J; Wang J; Zhang L; Zhang L; Xu Q; Shi K; Leptihn S; Shi Y; Fu X; Zhu P; Higgins PG; Yu Y
    Emerg Microbes Infect; 2021 Dec; 10(1):1404-1417. PubMed ID: 34170209
    [No Abstract]   [Full Text] [Related]  

  • 2. Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.
    Jo J; Ko KS
    Microbiol Spectr; 2021 Oct; 9(2):e0101021. PubMed ID: 34523993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.
    Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H
    Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iTRAQ-Based Differential Proteomic Analysis Reveals the Pathways Associated with Tigecycline Resistance in Acinetobacter baumannii.
    Yang N; Liu Y; He P; Ke R; Zhao Y; Feng Y; Jing R; Ma S; Liu C; Geng Y; Wu X; Wei Y
    Cell Physiol Biochem; 2018; 51(3):1327-1339. PubMed ID: 30481750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular epidemiology and resistance mechanisms of tigecycline-non-susceptible Acinetobacter baumannii].
    He X; Li H; Wang Q; Zhao C; Li S; Wang X; Zhang Y; Wang R; Yin Y; Jin L; Zhang F; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1218-1225. PubMed ID: 30152207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of insertion sequence Aba-1 and AdeS in reduced tigecycline susceptibility in MDR-Acinetobacter baumannii clinical isolates from Cairo, Egypt.
    Hassan R; Mukhtar A; Hasanin A; Ghaith D
    J Chemother; 2018 Apr; 30(2):89-94. PubMed ID: 29108486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase.
    Chen Q; Li X; Zhou H; Jiang Y; Chen Y; Hua X; Yu Y
    J Antimicrob Chemother; 2014 Jan; 69(1):72-6. PubMed ID: 23928024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America.
    Costello SE; Gales AC; Morfin-Otero R; Jones RN; Castanheira M
    Microb Drug Resist; 2016 Jun; 22(4):253-8. PubMed ID: 26716768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant Acinetobacter baumannii Isolates of Clinical Origin.
    Haeili M; Abdollahi A; Ahmadi A; Khoshbayan A
    Chemotherapy; 2021; 66(3):99-106. PubMed ID: 33823517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance.
    Lin MF; Lin YY; Tu CC; Lan CY
    J Microbiol Immunol Infect; 2017 Apr; 50(2):224-231. PubMed ID: 26055688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates.
    Li H; Wang X; Zhang Y; Zhao C; Chen H; Jiang S; Zhang F; Wang H
    Future Microbiol; 2015; 10(3):337-46. PubMed ID: 25812457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of mutations and hotspots in transcription regulators of resistance-nodulation-cell division efflux pumps in tigecycline non-susceptible Acinetobacter baumannii in China.
    Xu Q; Hua X; He J; Zhang D; Chen Q; Zhang L; Loh B; Leptihn S; Wen Y; Higgins PG; Yu Y; Zhou Z
    Int J Med Microbiol; 2020 Dec; 310(8):151464. PubMed ID: 33130415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of
    Yang Y; Liu X; Zhou D; He J; Chen Q; Xu Q; Wu S; Zhang W; Yao Y; Fu Y; Hua X; Yu Y; Wang X
    Microbiol Spectr; 2023 Jun; 11(3):e0459422. PubMed ID: 37184390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.
    Trebosc V; Gartenmann S; Royet K; Manfredi P; Tötzl M; Schellhorn B; Pieren M; Tigges M; Lociuro S; Sennhenn PC; Gitzinger M; Bumann D; Kemmer C
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7263-7271. PubMed ID: 27671072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Efflux Pump System and Other Drug Resistance Related Gene Mutations in Tigecycline-Resistant
    Zheng W; Huang Y; Wu W; Zhu J; Zhang T
    Comput Math Methods Med; 2023; 2023():8611542. PubMed ID: 36846201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acinetobacter baumannii Repeatedly Evolves a Hypermutator Phenotype in Response to Tigecycline That Effectively Surveys Evolutionary Trajectories to Resistance.
    Hammerstrom TG; Beabout K; Clements TP; Saxer G; Shamoo Y
    PLoS One; 2015; 10(10):e0140489. PubMed ID: 26488727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
    Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
    Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant Acinetobacter baumannii from a worldwide survey.
    Lucaßen K; Müller C; Wille J; Xanthopoulou K; Hackel M; Seifert H; Higgins PG
    J Antimicrob Chemother; 2021 Jun; 76(7):1724-1730. PubMed ID: 33760099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of eravacycline resistance in Acinetobacter baumannii mediated by a deletion mutation in the sensor kinase adeS, leading to elevated expression of the efflux pump AdeABC.
    Shi Y; Hua X; Xu Q; Yang Y; Zhang L; He J; Mu X; Hu L; Leptihn S; Yu Y
    Infect Genet Evol; 2020 Jun; 80():104185. PubMed ID: 31923725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.